SEC Company Response from StemGen, Inc. (CIK 0001023198) — Jul 29, 2020
StemGen, Inc. (CIK 0001023198)
Date: July 29, 2020 · CIK: 0001023198 · Accession: 0001161697-20-000337
AI Filing Summary & Sentiment
File numbers found in text: 333-235837
Letter
Re: StemGen, Inc. (the “Company”)
July 29, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington D.C. 20549
Registration Statement on Form S-1 (File No. 333-235837)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 9:30 AM. Eastern Time on July 30, 2020 or as soon thereafter as is practicable.
The Company hereby acknowledges that:
* should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
* the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
* the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Sincerely,
StemGen, Inc.
Show Raw Text
CORRESP 1 filename1.htm July 29, 2020 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington D.C. 20549 Re: StemGen, Inc. (the “Company”) Registration Statement on Form S-1 (File No. 333-235837) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 9:30 AM. Eastern Time on July 30, 2020 or as soon thereafter as is practicable. The Company hereby acknowledges that: * should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; * the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and * the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Sincerely, StemGen, Inc. /s/ Simon Dawson Simon Dawson, Chief Executive Officer